Novadiscovery announces Nature Communications paper on modeling the disruption to respiratory scientific trials resulting from mitigation measures in opposition to COVID-19
Model makes use of digital populations and in silico trials to point out impression on scientific trials and recommend diversifications to trial design
Lyon, France – 13 April 2022: Novadiscovery (NOVA), a number one well being tech firm utilizing in silico scientific trials to foretell drug efficacy and optimize scientific trial improvement, at present announces the publication of a novel mannequin of respiratory tract infections (RTI) in Nature Communications to deal with the uncertainties ensuing from non-pharmaceutical interventions (NPIs) in opposition to COVID-19 on scientific trials. The paper was printed in collaboration with NOVA’s associate OM Pharma.
Novadiscovery
François-Henri Boissel, Chief Executive Officer
Email: contact@novadiscovery.com
Consilium Strategic Communications
Sukaina Virji, Kris Lam, Isabelle Abdou
Email: novadiscovery@consilium-comms.com
About Novadiscovery
Novadiscovery is a number one well being tech firm utilizing in silico scientific trials to foretell drug efficacy and optimize scientific trial improvement. The Company goals to enhance R&D productiveness and maximize affected person outcomes by predicting the scientific good thing about a possible new drug candidate via laptop simulation, forward of human trials.
Novadiscovery’s progressive method leverages illness modeling and simulation experience accrued over the previous decade and combines mathematical fashions of illnesses and potential new therapies with digital sufferers in its built-in scientific trial simulation platform, JINKO®.
Novadiscovery is headquartered in Lyon, France and has a workforce of round 30 scientists, engineers & clinicians who work on the interface of biology, pharmacology, arithmetic & laptop science.
For extra info, please go to https://www.novadiscovery.com and observe us on Twitter @novadiscovery and linkedin.com/firm/novadiscovery
